"10.1371_journal.pone.0132559","plos one","2015-07-10T00:00:00Z","Nour Al-Sawalha; Indira Pokkunuri; Ozozoma Omoluabi; Hosu Kim; Vaidehi J Thanawala; Adrian Hernandez; Richard A Bond; Brian J Knoll","Department of Pharmacological and Pharmaceutical Sciences, University of Houston, 4800 Calhoun Road, Houston, Texas, 77204, United States of America; Department of Biology and Biochemistry, University of Houston, 4800 Calhoun Road, Houston, Texas, 77204, United States of America","Conceived and designed the experiments: BJK RAB NS. Performed the experiments: NS IP AH OO HK. Analyzed the data: NS IP RAB BJK VT. Wrote the paper: NS VT RAB BJK.","Brian J. Knoll is an Academic Editor for PLOS ONE. RA Bond is a co-inventor on a provisional patent application 2011, joint between MD Anderson and the University of Houston - The steroid-sparing effects of betaadrenergic inverse agonists. At this point this patent has not been assigned and has no value or license agreement in place or pending issuance. RA Bond is also a minor shareholder in Invion, a company in which he was scientific co-founder. RA Bond sold off almost his entire stock ownership and now owns ~$10,000 worth of stock (as of 12 June 2015). RA Bond has no other role than shareholder with Invion, and is not on any board and has no consulting agreement. This does not alter the authors adherence to PLOS ONE Editorial policies and criteria.","2015","07","Nour Al-Sawalha","NAS",8,TRUE,3,5,5,4,TRUE,TRUE,FALSE,0,NA,FALSE
